Ignite Creation Date:
2025-12-25 @ 3:13 AM
Ignite Modification Date:
2026-02-22 @ 9:04 AM
Study NCT ID:
NCT02062905
Status:
COMPLETED
Last Update Posted:
2019-09-11
First Post:
2014-02-11
Is NOT Gene Therapy:
True
Has Adverse Events:
True
Brief Title:
OTX-14-001: A Phase 2 Study Evaluating the Safety and Efficacy of OTX-DP for the Treatment of Chronic Allergic Conjunctivitis
Sponsor:
Ocular Therapeutix, Inc.
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2014-03
Start Date Type:
None
Primary Completion Date:
2014-08
Primary Completion Date Type:
ACTUAL
Completion Date:
2014-11
Completion Date Type:
ACTUAL
First Submit Date:
2014-02-11
First Submit QC Date:
None
Study First Post Date:
2014-02-14
Study First Post Date Type:
ESTIMATED
Results First Submit Date:
2016-02-29
Results First Submit QC Date:
None
Results First Post Date:
2016-05-09
Results First Post Date Type:
ESTIMATED
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2019-08-28
Last Update Post Date:
2019-09-11
Last Update Post Date Type:
ACTUAL